🇺🇸 FDA
Patent

US 11564926

Methods of synthesizing thyroid hormone analogs and polymorphs thereof

granted A61KA61K31/50A61K31/53

Quick answer

US patent 11564926 (Methods of synthesizing thyroid hormone analogs and polymorphs thereof) held by Madrigal Pharmaceuticals, Inc. expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Madrigal Pharmaceuticals, Inc.
Grant date
Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/50, A61K31/53, A61P, A61P5/14